Who are Bright Minds Biosciences Inc.'s main suppliers?

Bright Minds Biosciences Inc. (DRUG) key suppliers include: UIC, Aardvark Therapeutics, Inc.. View the full supplier network at chainsifter.com/chain/DRUG.

Who are Bright Minds Biosciences Inc.'s major customers?

Bright Minds Biosciences Inc. (DRUG) key customers include: AstraZeneca PLC, B-C-LTD. View the full customer network at chainsifter.com/chain/DRUG.

What sector is Bright Minds Biosciences Inc. in?

Bright Minds Biosciences Inc. (DRUG) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Bright Minds Biosciences Inc. (DRUG): 5 Verified Supply Chain Relationships

2Suppliers

2Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Bright Minds Biosciences Inc. (DRUG) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

1Distinct source URLs

3High confidence

0.780Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Bright Minds Biosciences Inc. Suppliers

Ticker	Name	Confidence	Evidence
UIC	UIC	92%	Pursuant to the terms and conditions of the Exclusive License Agreement, UIC granted the Company an exclusive license to the Inventions
AARD	Aardvark Therapeutics, Inc.	72%	Reciprocal relationship from AARD graph: Reciprocal relationship from DRUG graph: Reciprocal relationship from AARD graph: , operating results, prospects or financial condition. Risks Related to Arti…

Bright Minds Biosciences Inc. Customers

Ticker	Name	Confidence	Evidence
AZN	AstraZeneca PLC	62%	Reciprocal relationship from AZN graph: Reciprocal relationship from DRUG graph: Reciprocal relationship from AZN graph: Reciprocal relationship from DRUG graph: Reciprocal relationship from AZN grap…
B-C-LTD	B-C-LTD	62%	declare dividends, any gain on your investment will need to result from an appreciation in the price of our Common Shares. There will therefore be fewer ways in which you are able to make a gain on y…

Bright Minds Biosciences Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
DRUG-DEBT	Debt stack $59,536	90%	Market cache reports total debt of $59,536.

Bright Minds Biosciences Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bright Minds Biosciences Inc..

Bright Minds Biosciences Inc. Ownership

Holder	Name	Confidence	Evidence
DRUG-OWNER-JANUS-HENDERSON-GROUP-PLC	JANUS HENDERSON GROUP PLC	90%	13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 93 tracked holders.

Bright Minds Biosciences Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SCLX	Scilex Holding Company	100.00	2
AARD	Aardvark Therapeutics, Inc.	100.00	1	['supplier']
NBIX	Neurocrine Biosciences, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	1	['customer']
DRTSW	Alpha Tau Medical Ltd.	50.00	2
CORT	Corcept Therapeutics Incorporated	50.00	2
DEO	Diageo plc	50.00	2
ALLO	Allogene Therapeutics, Inc.	50.00	2
CCCC	C4 Therapeutics, Inc.	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
HCM	HUTCHMED (China) Limited	50.00	2
ALLR	Allarity Therapeutics, Inc.	50.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	50.00	2
BCAX	Bicara Therapeutics Inc.	50.00	2
CPMV	Mosaic ImmunoEngineering, Inc.	50.00	2
CRNX	Crinetics Pharmaceuticals, Inc.	50.00	2
CHRS	Coherus Oncology, Inc.	50.00	2
ASML	ASML Holding N.V.	50.00	2
CLLS	Cellectis S.A.	50.00	2
CYTK	Cytokinetics, Incorporated	50.00	2

Bright Minds Biosciences Inc. Supply Chain